Development of a Purification Process for Adenovirus: Controlling Virus Aggregation to Improve the Clearance of Host Cell DNA
- 5 September 2008
- journal article
- Published by Wiley in Biotechnology Progress
- Vol. 21 (2) , 466-472
- https://doi.org/10.1021/bp049644r
Abstract
The clearance of host cell DNA is a critical goal for purification process development for recombinant Ad5 (rAd5) based vaccines and gene therapy products. We have evaluated the clearance of DNA by a rAd5 purification process utilizing nuclease digestion, ultrafiltration, and anion exchange (AEX) chromatography and found residual host cell DNA to consistently reach a limiting value of about 100 pg/1011 rAd5 particles. Characterization of the purified rAd5 product using serial AEX chromatography, hydroxyapatite chromatography, or nuclease treatment with and without particle disruption showed that the residual DNA was associated with virus particles. Using a variety of additional physical characterization methods, a population of rAd5 virus in an aggregated state was detected. Aggregation was eliminated using nonionic detergents to attenuate hydrophobic interactions and sodium chloride to attenuate electrostatic interactions. After implementation of these modifications, the process was able to consistently reduce host cell DNA to levels at or below 5 pg/1011 rAd5 particles, suggesting that molecular interactions between cellular DNA and rAd5 are important determinants of process DNA clearance capability and that the co‐purifying DNA was not encapsidated.Keywords
This publication has 26 references indexed in Scilit:
- Propagation of Adenoviral VectorsPublished by Elsevier ,2007
- Protection against Mucosal Simian Immunodeficiency Virus SIV mac251 Challenge by Using Replicating Adenovirus-SIV Multigene Vaccine Priming and Subunit BoostingJournal of Virology, 2004
- Recent Advances in the Development of HIV-1 Vaccines Using Replication-Incompetent Adenovirus VectorsAnnual Review of Medicine, 2004
- Gene therapy progress and prospects: adenoviral vectorsGene Therapy, 2003
- Cancer gene therapy: an awkward adolescenceCancer Gene Therapy, 2003
- Live recombinant vectors for AIDS vaccine development.Current Molecular Medicine, 2003
- Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector BoostingJournal of Virology, 2003
- Molecular Therapies for Colorectal Cancer Metastatic to the LiverMolecular Therapy, 2002
- New Helper Cells and Matched Early Region 1-Deleted Adenovirus Vectors Prevent Generation of Replication-Competent AdenovirusesHuman Gene Therapy, 1998
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977